Template CTD Dossier (without supply)

rss
 
noimage.gif
1. An entirely new combination. An original analgesic, which is not a scheduled drug. 2. The combination is in complete compliance with a global trend of multimodal analgesia.  3.  The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.   The conditions for licensing-out selling of the product. 1. Documents to be transferred:   -     Pharmaceutical...
noimage.gif
Farmavita.Net members, from India,  are offering  license-out  of formulation documentation for more than two hundred (200)  pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include  clincal studies.   Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.  It is expected that buyer of...

Advert search

Recent adverts

A pharmaceutical company from Turkey, selling...
330 Views
Wuxi Griffin Pharmaceuticals Co. Ltd. is...
282 Views
A pharmaceutical company from Turkey, selling...
317 Views
Active substance formulated into Tivortin®  –...
351 Views
1. An entirely new combination. An original...
310 Views
I’m a representative of Parafarm (Penza,...
1137 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
1025 Views